tiprankstipranks
pc:quell

Quell Therapeutics

80 Wood Lane, Translation & Innovation Hub, Imperial College White City Campus, London, London W12 0BZ, GB
https://www.quell-tx.com/
Quell Therapeutics is a biotechnology company developing engineered regulatory T cell (Treg) therapies aimed at treating autoimmune and inflammatory diseases. The company employs a cell‑engineering platform to generate and optimize antigen‑specific Tregs designed to restore immune tolerance and achieve targeted, durable immune regulation with reduced broad immunosuppression.

Leadership & Board

Current Number of Employees117
Current LinkedIn Followers20,406

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$156M
Total Amount Raised$156M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$156M
Latest Funding Amount$156M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Company Momentum Positive

Articles Published on TipRanks3
Articles Published on TipRanks
3
LinkedIn Trend+0.55% followers
LinkedIn Trend
+0.55% followers
Workforce Trend1.7% employees
Workforce Trend
1.7% employees
Quell Therapeutics LinkedIn following is increasing, signaling rising market interest, while its workforce size remains relatively unchanged.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Dec 29, 2021
Series B
$156.00M

Investors

Investor Name
Funding Round

Related News and Analysis